Shreepad Shree Vallabh Phytopharmaceuticals (India)

Shreepad Shree Vallabh, SSV Phytopharmaceuticals is an India-based nutraceutical and healthcare company that develops patented NDDS technologies, including Advanced Liposomal and Aquasol Technology, to enhance the bioavailability and efficacy of vitamins, minerals, and phytoactives. The company states it is India's only manufacturer of Creatine Monohydrate, Creatine HCL, CoQ10 (Ubiquinone) and Advanced Liposomes, and it presents platform technologies including Aquasol Technology, NeoCriSomes Technology, and FMNE Technology. Its stated mission centers on enhanced bioavailability and efficacy, global accessibility, and research-backed products.

Shreepad Shree Vallabh Phytopharmaceuticals was founded in 2019, marking the beginning of its journey in innovation-driven nutraceuticals. In 2020, during Covid-19, it developed and patented the formulation CURVIC, conducted clinical trials, and published preclinical data in reputed journals like Nature; the formulation showed effectiveness in Covid-19 patients and received global appreciation for Dr. Yogesh Dound. In 2021, post-pandemic, the focus shifted back to advancing technology development and research activities. During 2022–2023, major focus was on the development and validation of Aquasol and Liposomal Technologies, strengthening its innovation pipeline. In 2023, a commercial breakthrough followed.

Patented, clinically proven nutraceutical solutions blending nature with advanced science.

• Creatine Monohydrate

  Product listed under Aquasol Technology.

• Creatine Hydrochloride

  Product listed under Aquasol Technology.

• Coenzyme Q10

  Product listed under Aquasol Technology.

• Vegan Vitamin D3

  Product listed under FMNE Technology.

• Curvic Ptyron

  Product listed under FMNE Technology.

1. 1Home - ssvphytopharma.netssvphytopharma.net
2. 2About Us - ssvphytopharma.netssvphytopharma.net